Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

COVID-19 linked to increased asthma risk—vaccine offers protection

  • medicalxpress.com language
  • 2025-08-15 01:11 event
  • 4 days ago schedule
COVID-19 linked to increased asthma risk—vaccine offers protection
People who have had COVID-19 are at increased risk of developing certain inflammatory diseases of the airways, such as asthma, hay fever and chronic sinusitis. However, vaccination against the SARS-CoV-2 virus appears to reduce the risk, according to a comprehensive epidemiological study led by researchers at Karolinska Institutet.

138. Targeting immune cells to improve long-term survival in organ transplantation

  • 4 days ago schedule
  • medicalxpress.com language

Northwestern Medicine scientists have discovered how a subset of immune cells are essential for successful organ transplantation acceptance and that therapeutically targeting them may improve long-term survival post-transplant, according to a recent study published in The Journal of Clinical Investigation.

139. At least 40 dead in Sudan's worst cholera outbreak in years

  • 4 days ago schedule
  • medicalxpress.com language

Cholera has claimed at least 40 lives in Sudan's Darfur region over the last week as the country weathers its worst outbreak in years, Doctors Without Borders (MSF) said on Thursday.

140. Slowdown in progress found with cancer survival in England and Wales

  • 4 days ago schedule
  • medicalxpress.com language

Survival for all cancers combined has increased dramatically since the 1970s, but progress has slowed down in the past 10–15 years, according to a study by the London School of Hygiene & Tropical Medicine (LSHTM).

141. Bridging the pain divide: Study shows rural-urban gap persists despite adjustments

  • 4 days ago schedule
  • medicalxpress.com language

A study published in The Journal of Rural Health sheds new light on the persistent and troubling disparities in chronic pain prevalence between rural and urban populations in the United States.

142. Indigenous researcher revives traditional medical practices of his people

  • 4 days ago schedule
  • medicalxpress.com language

A study by ethnobotanist Hemerson Dantas dos Santos Pataxó Hãhãhãi has revived the ancestral healing knowledge of his Indigenous people. Currently a doctoral student at the Institute of Environmental, Chemical, and Pharmaceutical Sciences at the Federal University of São Paulo (ICAQF-UNIFESP) in Brazil, he belongs to the Pataxó Hã-Hã-Hãi people. According to his doctoral advisor, Eliana Rodrigues, he is the world's first Indigenous ethnobotanical researcher.

143. Smoking cessation app with real-time support nearly doubles quit rates in clinical trial

  • 4 days ago schedule
  • medicalxpress.com language

While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among people with low incomes, leading to health disparities. A smartphone app that delivers real-time, tailored messages may hold the key to helping them quit, according to University of Oklahoma clinical trial results published in JAMA Network Open.

144. Double trouble: Epigenetic duo shapes cell fate and disease

  • 4 days ago schedule
  • medicalxpress.com language

Shedding light on what determines how cells become what they are meant to be—nerves, bone, muscles, etc.—can also help researchers understand how diseases develop when these biological programs break down. Now, researchers at Case Western Reserve University have discovered a key synergistic role for two epigenetic markers—molecules that help tell genes to turn on and off—involved in programming cell fate. Importantly, turning off these two markers causes genes to over-activate, disrupting normal cell development.

145. Novel monoclonal antibody targets deadly sepsis by preventing 'cytokine storms'

  • 4 days ago schedule
  • medicalxpress.com language

Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal antibody to stop sepsis, a deadly full-body infection. The antibody also has the potential to treat a broad array of other inflammatory conditions, including autoimmune disorders, their research indicates.

146. Rising colorectal cancer found among young adults in Sweden

  • 4 days ago schedule
  • medicalxpress.com language

The underlying causes of this increase are not fully understood. The researchers note that the trend does not appear to be driven by known risk factors for colorectal cancer in younger people, such as inflammatory bowel disease and hereditary factors. Instead, environmental and lifestyle factors early in life may play a role.

147. COVID-19 linked to increased asthma risk—vaccine offers protection

  • 4 days ago schedule
  • medicalxpress.com language

People who have had COVID-19 are at increased risk of developing certain inflammatory diseases of the airways, such as asthma, hay fever and chronic sinusitis. However, vaccination against the SARS-CoV-2 virus appears to reduce the risk, according to a comprehensive epidemiological study led by researchers at Karolinska Institutet.

148. Novel drilling plate shows promise in preclinical dental training

  • 4 days ago schedule
  • medicalxpress.com language

A novel drilling plate simulating the tactile and structural properties of natural human dental tissues may provide dental students with increasingly realistic training opportunities in the preclinical phase. The new drilling plate was assessed by dental educators as part of an international study led by the University of Eastern Finland.

149. New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk

  • 4 days ago schedule
  • medicalxpress.com language

Preventing and managing high blood pressure with healthy lifestyle behaviors, such as following a heart-healthy diet including reducing salt intake, staying physically active, maintaining a healthy weight and managing stress—combined with early treatment with medication to lower blood pressure if necessary—are recommended to reduce the risk of heart attack, stroke, heart failure, kidney disease, cognitive decline and dementia, according to a new clinical guideline published in Circulation, Hypertension, and in JACC.

150. Laying the foundation for gene editing for inherited progressive deafness in adults

  • 4 days ago schedule
  • medicalxpress.com language

A study, published in the Journal of Clinical Investigation titled "Single Dose Genome Editing Therapy Rescues Auditory and Vestibular Functions in Adult Mice with DFNA41 Deafness," provides an example of a successful use of gene-editing technology to treat a mouse model of human genetic hearing loss.

151. Immunotherapy helps extend the lives of patients with rare form of skin cancer

  • 4 days ago schedule
  • medicalxpress.com language

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system attack cancer cells, can effectively shrink or eliminate tumors in patients with unresectable advanced desmoplastic melanoma, a rare and often aggressive form of skin cancer.

152. Mortality associated with fine particles from wildfires may be underestimated by 93%

  • 4 days ago schedule
  • medicalxpress.com language

Wildfire smoke contains pollutants that are hazardous to health, including fine particles (PM2.5), which have been linked to increased mortality and morbidity. A new study by the Barcelona Institute for Global Health (ISGlobal), provides strong evidence that PM2.5 from wildfires poses a greater mortality risk than non-fire-related particles. The results, published in The Lancet Planetary Health, also indicate that mortality associated with wildfire smoke may be underestimated by 93%.

153. Six in 10 children with asthma meet guideline diagnostic criteria

  • 4 days ago schedule
  • medicalxpress.com language

Roughly two-thirds of children with pediatrician-diagnosed asthma have a confirmed diagnosis in accordance with international guideline criteria requiring two or more positive objective tests, according to a study published online Aug. 8 in Pediatric Pulmonology.

154. Protein-bound microplastics can disrupt brain cells and potentially cause neurotoxicity

  • 4 days ago schedule
  • medicalxpress.com language

A research team revealed that microplastics introduced into the body may bind to proteins in vivo, disrupt the function of brain cells, and act as neurotoxicants. Based on proteomics analysis, the study precisely demonstrated how microplastics bound to proteins alter biological properties in the body and cause inflammatory responses and cellular function disruptions.

155. MedDiet adherence seems beneficial for benign prostatic hyperplasia

  • 4 days ago schedule
  • medicalxpress.com language

In patients with benign prostatic hyperplasia (BPH), adherence to the Mediterranean diet (MedDiet) is associated with improved urinary function and reduced lower urinary tract symptoms (LUTS), according to a study published online July 6 in The Prostate.

156. Mutational signatures and tumor activity identified in Chinese patients

  • 4 days ago schedule
  • medicalxpress.com language

Many different mutational signatures, or "fingerprints" of DNA damage have been identified across different tumor types which can provide a record of environmental exposure or clues about the etiology of carcinogenesis. Most of the mutational signature characterization has been performed using tumors from American and European populations due to the availability of sequencing data in these regions from large-scale atlases such as The Cancer Genome Atlas and the International Cancer Genome Consortium. While some unique mutational signatures have been identified in various Asian populations, mutational signatures and their activity in tumors from Chinese patients have not been well characterized across cancer types.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.